US 9,845,471 B2Granted

Compositions and methods for treating pancreatic cancer

AssigneeFred Hutchinson Cancer Research Center

InventorSunil R. Hingorani

Life of this patent

Estimating the term…

Abstract

The present disclosure provides compositions and methods for treating or reducing the risk of pancreatic cancer by administering compounds capable of inhibiting the expression or activity of RUNX3.

Claims5

Dependent claims

A method for reducing the risk of pancreatic cancer metastasis, comprising administering to a subject in need thereof an inhibitor of RUNX3 expression or activity.

Dependencies are inferred from the claim text.

Facts

Application: 14/760,940Filed 14 Jan 2014 · us provisional application
Priority: 15 Jan 2013
Published: US 2015/0368646 A124 Dec 2015
Granted: 19 Dec 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification14 codes

C12N 15/1135
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming…: against…
A61K 31/713
Compounds having three or more nucleosides or nucleotides: double-stranded nucleic acids or oligonucleotides
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 35/00
Antineoplastic agents

Family

Application61/752,819Us provisional application · filed 15 Jan 2013
US 2015/0368646 A1Pre-grant publication · published 24 Dec 2015
US 9,845,471 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results